Anna Berkenblit, MD, MMSc
@aberkenblit
Chief Scientific & Medical Officer @PanCAN 💜 | Biotech Executive | Oncologist | Drug Developer
In Episode 2 of the PancChat Podcast, host @AlisynCamerota sits down with Dr. @ABerkenblit and @DrAllysonOcean to discuss how advocacy, research, and early detection are shaping the future of #pancreaticcancer care. 💜🎙️💬 Listen now on all major podcast platforms, including…
Ep. 3 of the new PancChat Podcast, a collaborative effort between @PanCAN and @LetsWinPC, is here, and it’s a must-listen! 🎧 @Aiims1742 @MDAndersonNews @nyulangone @Perlmutter_CC @HopkinsMedicine @AlisynCamerota
In this episode of 🎙️ PancChat, host @AlisynCamerota is joined by Dr. Michael Goggins and @Aiims1742 for an in-depth discussion about the risk factors for #pancreaticcancer. Together, they explore lifestyle, inherited, and disease-related risks, explain how genetics and new-onset…
Episode 3 of the Let's Win and @PanCAN's #PancChat Podcast is live! Listen as Dr. Anirban Maitra (@Aiims1742) of @MDAnderson @nyulangone and Dr. Michael Goggins of @HopkinsMedicine discuss #PancreaticCancer Risk Factors with @AlisynCamerota. share.transistor.fm/s/7c8193db
Great writeup by @aberkenblit @PanCAN on precision medicine approaches in #pancreaticcancer, including Dr Roychowdhury's @OSUCCC_James novel telemedicine-based clinical trial targeting FGFR2 (which happens to have been the focus of my PhD work, too!)
Precision medicine is gaining momentum in #pancreaticcancer. By identifying unique features in a patient’s tumor — like rare FGFR2 gene fusions — more personalized treatment options are becoming possible. 🧬🔬 An innovative new clinical trial is now making it easier for patients…
Precision medicine is gaining momentum in #pancreaticcancer. By identifying unique features in a patient’s tumor — like rare FGFR2 gene fusions — more personalized treatment options are becoming possible. 🧬🔬 An innovative new clinical trial is now making it easier for patients…
Had the privilege of meeting Dr. Sameek Roychowdhury (@OSUCCC_James) at #ASCO25. He’s leading an innovative clinical trial for FGFR2+ #pancreaticcancer that lets patients enroll where they already receive care. Learn more: pancan.org/news/research-…
![aberkenblit's tweet card. Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, [...] READ MORE](https://pbs.twimg.com/card_img/1947713834782797824/CH91KkW4?format=jpg&name=orig)
I’m grateful to the patients who shared their experiences through @PanCAN’s Patient Registry and proud to contribute data that can help shape better outcomes.
A new PanCAN-authored paper uses feedback provided by patients with #pancreaticcancer to identify trends in reporting pain. Among the key findings: Pain is more likely to be reported by pancreatic cancer patients who are younger than 65. And patients experiencing pain are also…
It was an honor to co-author this @JMIR_JoPM article with my @PanCAN colleagues, following through on our promise to patients to publish results from their participation in our Registry 💜 jopm.jmir.org/2025/1/e65046/
A new PanCAN-authored paper uses feedback provided by patients with #pancreaticcancer to identify trends in reporting pain. Among the key findings: Pain is more likely to be reported by pancreatic cancer patients who are younger than 65. And patients experiencing pain are also…
Thrilled to see this @AGA_Gastro paper published by Drs Suresh Chari, Ziding Feng, & colleagues, funded in part by @PanCAN & incl. my colleague @LynnMatrisian. Important findings about new-onset diabetes & #pancreaticcancer, with results varying by race. gastrojournal.org/article/S0016-…
Did you miss the latest #PancChat episode with host @AlisynCamerota, @PanCAN's Dr. @aberkenblit, and @drallysonocean? Listen live in your Twitter/X feed here: share.transistor.fm/s/846bf15a
I’m so excited about RAS inhibitors! 🧬🔬 Listen to Episode 2 of the all-new PancChat Podcast, where I discuss this and more with @DrAllysonOcean and host @AlisynCamerota. share.transistor.fm/s/846bf15a @PanCAN @letswinpc
📢 Global update on #PancreaticCancer from the WPCC @worldpcc member call! Dr. Anna Berkenblit @PanCAN shared key insights: 🔬 Precision medicine 🧬 KRAS inhibitors & vaccines 📊 #ASCO2025 updates 🧪 Early detection tools Here the full presentation 👇 i-pcc.org/news/state-of-…
🎙️ New #PancChat episode! Host @AlisynCamerota speaks with Dr. @aberkenblit, Chief Scientific & Medical Officer at @PanCAN, and @DrAllysonOcean of @WeillCornell, co-founder of Let's Win and chair of our Scientific Advisory Board. share.transistor.fm/s/846bf15a
PanCAN volunteers recently had the opportunity to tour the Rogel and Blondy Center for Pancreatic Cancer at @UMRogelCancer and connect with the incredible team driving progress forward. 🥼🤝 @UMICHpancreas shared, “Had the privilege of welcoming several amazing & dedicated…
I’m on Episode 2 of the all-new PancChat Podcast! 🎙️💬 Join @DrAllysonOcean and me as we talk with host @AlisynCamerota about the current state of #pancreaticcancer treatment and research. @PanCAN @LetsWinPC share.transistor.fm/s/846bf15a
In this episode of PancChat, host @AlisynCamerota speaks with Dr. @ABerkenblit, Chief Scientific and Medical Officer at @PanCAN, and @DrAllysonOcean of @WeillCornell, co-founder of @LetsWinPC and chair of its Scientific Advisory Board. They discuss the current state of…
PancChat can be found on all major podcast platforms! 🎙️ share.transistor.fm/s/846bf15a
Join us on Thursday for a panel discussion with members of our @PanCAN Patient Services team! RSVP today: pancan.org/patientservice…
I can't even begin to express what an honor and a privilege it is to work with this group, under @PanCAN 's leadership, and following the path of many amazing predecessors 🙏Thank you a million times over for the opportunity